New Labeling Solutions Emerge for UDI

Unique Device Identification requirements could be driving the need for new labeling solutions.   “Based on UDI coming in with needs for traceability, more information is needed to bring out to the different levels in the packaging of medical devices,” Markku Pietarinen, Manager, Business Segments & Pharma, Specials EMEIA, UPM Raflatac, tells MD+DI. “New materials are needed to comply with the needs for label materials that can be easily printed, converted for the use in the medical device industry packaging process, and also to label the device itself.”   UDI has already emerged in the United States, and now rules are evolving in the European Union. "In April 2017, the EU Commission formally adopted two new regulations on medical devices and in vitro diagnostic medical devices. One of the main regulatory updates is the implementation of a UDI system that provides a globally harmonized and consistent approach for the marking and identification of medical devices," Pietarinen explained in a news release. "A UDI is a code printed on a label affixed to a device or its packaging, or even directly on the device itself, in both plain text and machine-readable format. All medical devices available in the EU must comply with the new regulations by April 2020, with the deadline for in vitro diagnostic devices falling two years later, in 2022."   To help medical device companies with such expectations, UPM Raflatac will launch RPMD (Raflatac Permanent Medical Device) pr...
Source: MDDI - Category: Medical Devices Authors: Tags: Materials Source Type: news